Log In
BCIQ
Print this Print this
 

Abemaciclib (LY2835219)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSelective dual inhibitor of cyclin dependent kinase 4 (CDK4) and CDK6
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/13/2016

Undisclosed

Undisclosed

Undisclosed

12/10/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today